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Objective: The aim of the work described here was to measure the role of psychopathological features, specif-
ically impulsivity and depression, in suicidality in patients with temporal lobe epilepsy (TLE).
Methods: Neuropsychiatric evaluation of 66 outpatients with TLE was performed with the following instru-
ments: a structured clinical interview (Mini International Neuropsychiatric Interview Plus), the Barratt Im-
pulsiveness Scale, the Hamilton Anxiety Scale, the Beck Depression Inventory, and the Brief Psychiatric
Rating Scale.
Results: A current Axis I psychiatric diagnosis, mainly mood and anxiety disorders, was assigned to 37 sub-
jects (56.1%) Presence of suicide risk was identiﬁed in 19 patients (28.8%), and 14 (21.2%) had attempted sui-
cide. Frequency of seizures (P=0.012), current major depression (P=0.001), and motor impulsivity
(P=0.005) were associated with suicide risk on univariate analysis. Logistic regression stressed the main rel-
evance of major depression (OR=12.82, 95% CI=2.58–63.76, P=0.002) and motor impulsivity (OR=1.21,
95% CI=1.06–1.38, P=0.005) to suicide risk.
Conclusion: Depression has a major inﬂuence on suicidality in epilepsy. Motor impulsivity is also relevant and
may be an important component of depression in TLE associated with suicide risk.
© 2011 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
Epilepsy and suicide are two prevalent health conditions that may
be associated [1]. A number of recent reports have pointed out that
patients with epilepsy, mainly temporal lobe epilepsy (TLE), have
an increased risk of suicide [2-5]. A meta-analysis using standardized
mortality ratios (SMRs) conducted by Bell and co-workers [2] identi-
ﬁed that deaths by suicide in people with epilepsy were three times
higher than expected in the general population (SMR=3.3, 95% CI
2.8-3.7). These authors also highlighted increased rates of death by
suicide in patients with TLE (SMR 6.6, 95% CI 1.8-16.8) and after tem-
poral lobectomy (SMR 13.9, 95% CI=8.9–20.7) [2]. Conversely, peo-
ple who attempt suicide appear to be more prone to develop
seizures, pointing to possible bidirectional mechanisms [6].
Limbic epileptogenic areas in TLE, such as the amygdala, are in-
volved in social behaviors, including impulse control, anxiety, andcleo Avançado de Tratamento
to, 30110–934 Belo Horizonte
liveira).
ier OA license.emotional memory [7]. Altered serotonergic neurotransmission has
been described in epilepsy, depression, and impulsive and suicidal be-
havior [8]. A putative association between impulsivity, suicide,
and mood disorders has also been reported in the literature [9,10]. In
line with this, psychiatric disorders, particularly depression and anxi-
ety, are associated with suicidality in epilepsy [1,11]. Moreover, pa-
tients with suicidal behavior often have problems in cognitive
inhibition [8], and abnormalities in serotoninergic projections to pre-
frontal cortex (PFC) seem to play a role in this executive impairment.
Recently, Espinosa et al. found that executive dysfunction has a major
inﬂuence on suicide risk and attempts in TLE [12]. Barratt et al. pro-
posed that neurophysiological substrates of seizures may also predis-
pose to a hyperexcitable neuronal state responsible for impulsivity in
epilepsy [13].
There are limited data in the literature on factors associated with
suicide and epilepsy in different cultural and socioeconomic settings
[12]. Such studies can throw light on the pathogenesis of suicide
and might help elucidate the extent to which epilepsy and psycho-
pathological factors account for suicide risk. Therefore, we conducted
a cross-sectional study in Brazil to assess clinical and psychopatholog-
ical features associated with suicidality in TLE, as well as to measure
the effect of impulsivity and depression.
Table 1





Gender, female 35 53%





Educational level, years of study 7 (3.4) 6.5 (0–12)
Marital statusb
Single 25 37.9%






Retired (age or time of service purposes) 6 9.1%
Retired (due to illness) 21 31.8%
Seizure type
Simple partial 28 42.4%
Complex partial 63 95.5%
Secondarily generalized 24 36.4%
Age at onset of epilepsy, years 8.9 (10.2) 6.5 (0–49)
Duration of epilepsy, years 31 (12.5) 30 (3–54)
Seizure frequency, seizures/month 5.2 (7.8) 2.5 (0–40)
Seizure free ≥12 months 2 3%
MRI
Mesial temporal sclerosis (MTS)
Without MTS 10 15.2%
Right MTS 23 34.8%
Left MTS 26 39.4%
Bilateral MTS 7 10.6%
AED therapy regime
Monotherapy 9 13.6%
Two AEDs 41 62.1%
Three AEDs 16 24.2%
a Mixed race or color (mulato, mestizo).
b One patient failed to disclose marital status.
Table 2
Suicidality according to the MINI Plus (N=66).
Suicidality aspect n Proportion
Lifetime suicide attempt 14 21.2%
Presence of current suicide risk 19 28.8%
Severity of suicide risk
Low (1–5 points) 13 19.7%
Moderate (6–9 points) 1 1.5%
High (N9 points) 5 7.6%
High suicide risk and lifetime suicide attempt 4 6,1%
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After previous written informed consent and approval by the local
ethics committee, 66 outpatients recruited from the Epilepsy Section
of the Hospital das Clínicas, Universidade Federal de Minas Gerais,
Brazil, were evaluated. This epilepsy section is a specialized tertiary
service that treats more than 1000 patients with different epilepsy
syndromes.
Psychiatric Axis I diagnoses were established using the Mini Inter-
national Neuropsychiatric Interview (MINI) Plus, Version 5.0.0.
[14,15]. This instrument accesses lifetime and current psychiatric dis-
orders. Of note, the term current was used here to indicate that the
patient has the disease at present, regardless of his or her past history.
Lifetimemeans that the patient has had at least one episode of the dis-
order during his or her life, even those whose single episode is still
present. Suicidality was evaluated with the suicide module of the
MINI Plus, which consists of six items (0–33 points) that assess life-
time suicide attempts and the presence and level (1–5 low, 6–9 mod-
erate, N9 high) of current suicide risk [16]. In this study we
established the presence of suicide risk if the patient scored ≥1
point on the MINI Plus suicidality module. In addition, the Beck De-
pression Inventory (BDI, total score range: 0–63) [17,18], Hamilton
Anxiety Scale (HAM-A, total score range: 0–56) [19,20], and Brief Psy-
chiatric Rating Scale (BPRS, total score range: 0–108) [21,22] were
used to quantify depressive, anxiety, and general psychopathology,
respectively.
The Brazilian version of the Barratt Impulsiveness Scale (BIS-11)
[23] was used to assess impulsivity. This 30 item self-reported scale
has an overall (total) impulsivity score ranging from 30 to 120 points.
The scale is also divided into three subscales: Motor Impulsivity (a
tendency to act without thinking or considering consequences),
Non-planning Impulsivity (characterized as a “present orientation”
or a lack of “futuring”), and Attentional Impulsivity (a “cognitive in-
stability” with difﬁculties in “focusing on the task at hand”) [24].
Descriptive analysis of categorical variables and proportions was
performed. Patients were divided into two groups, with and without
suicide risk, according to the MINI Plus and were compared by means
of univariate and multivariate analyses. For comparison of categorical
variables, the χ2 test and Fisher's exact test were performed; contin-
uous variables were evaluated using the Mann–Whitney U test.
Spearman's ρ was used to investigate the correlations between psy-
chopathological scores and to address their colinearity. Logistic re-
gression was conducted to ascertain which variables signiﬁcantly
predicted suicide risk. All these analyses were performed using SPSS
Version 15.0; statistical signiﬁcance was set at the 0.05 level of
conﬁdence.
3. Results
Clinical and sociodemographic features of 66 patients with TLE are
summarized in Table 1. Carbamazepine was the most prescribed
drug, taken by 65% of the patients, and benzodiazepines, as a group,
were being taken by 47 patients (71%). There were 31 men (47%)
and 35 women (53%), and the majority of the sample were not
employed (54.5%). Participants had had seizures for an average of
31 years (SD=12.5), and average age at seizure onset was 9 years
(SD=10.2). Only 2 participants (3%) achieved seizure control for at
least 1 year.
Forty-ﬁve patients (68.2%) were diagnosed with a lifetime Axis I
psychiatric disorder, and 37 (56.1%) presented with a current diagno-
sis. A lifetime depressive episode was identiﬁed in 28 patients
(42.4%). Current major depressive disorder was diagnosed in 13
(19.7%) patients. Bipolar disorder was diagnosed in 7 (10.6%), 3
with type I (4.5%) and 4 with type II (6.1%). Four of these patients
(6.1%) presented with current bipolar depressive episode and only
one patient (1.5%) exhibited a manic state at assessment. Anxietydisorders were observed in 29 (43.9%), psychoses in 3 (4.5%), somato-
form disorders in 10 (15.2%), and substance-related disorders in 2
(3%) patients. Of note, some patients had more than one diagnosis.
Suicide risk evaluation is described in Table 2.
Table 2 indicates that most patients with suicidality exhibited a
low suicide risk (68.4% of the patients with suicide risk). On the
other hand, an impressive portion of the sample had a high suicide
risk (7.6%), and the majority of patients with increased risk had previ-
ously attempted suicide. To evaluate the clinical variables associated
with suicide risk the sample was divided into two groups: one group
with low or greater suicide risk (MINI Plus suicidality module ≥1
point), and a second group with no suicidality at all (MINI Plus suicid-
ality module=0). There were no signiﬁcant statistical differences be-
tween groups, with or without suicide risk, in sociodemographic
variables (sex, age, ethnic group, marital status, employment), age at
onset, duration of the epilepsy, seizure type, mesial temporal sclerosis
laterality, number of antiepileptic drugs (AEDs), or use of any AED
Table 4
Logistic regression with variables associated with suicide risk in TLE.
Odds ratio 95% CI P value
Major depression 12.82 2.58–63.76 0.002
Barratt Impulsiveness Scale, Motor Impulsivity 1.21 1.06–1.38 0.005
Frequency of seizures 1.03 0.96–1.11 0.428
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differed statistically between groups (P=0.012), as patients with sui-
cide risk had a mean (SD) of 8.26 (9.5) seizures/month and those
without suicide risk had a mean (SD) of 3.91 (6.7) seizures/month.
Table 3 is a psychopathological comparison between groups with
and without suicide risk.
Patients with suicide risk manifested higher levels of psychopa-
thology, chieﬂy depressive symptoms, on BDI scores. Depression
was the only psychiatric disorder correlated with suicide risk, though
somatoform disorder was also relevant. Additionally, suicide risk was
associated with impulsivity. Data described in Table 3 stress that the
motor domain is, in fact, the relevant component of impulsivity asso-
ciated with suicide risk.
The relevance of motor impulsivity to suicide risk is also demon-
strated by the positive correlation of the severity of suicide risk scores
with the BIS Motor subscale scores (Spearman's ρ=0.311, P=0.011),
but not with the BIS Total scores or the other BIS subscale scores
(PN0.05, for all). Severity of suicide risk total scores were associated
with BDI (Spearman's ρ=0.471, Pb0.001), HAM-A (Spearman's
ρ=0.347, P=0.004), and BPRS (Spearman's ρ=0.323, P=0.009)
scores.
When patients with suicide attempts were compared with those
who had never attempted suicide, only lifetime major depression
(χ²=4.7 [1.3–17.2], P=0.02) and somatoform disorders group
(χ²=5.2 [1.2–21.8], P=0.03) were statistically signiﬁcant. It is im-
portant to note that depressive symptoms are an important compo-
nent of somatoform disorders as shown by their association with
BDI scores (Pb0.001), and this may explain the association of somato-
form disorders with suicide risk. There was no association between
suicide attempts and BIS (total or separate subscale) scores.
Logistic regression was conducted to assess whether the predictor
variables—current major depression, motor impulsivity, and frequency
of seizures—signiﬁcantly predicted suicide risk. HAM-A and BPRS
were excluded from the logistic regression because of the high colinear-
itywith BDI (Spearman's ρ=0.768 and 0.647, respectively; Pb0.001 for
both). BIS Motor scores correlated with psychiatric symptoms mea-
sured with the BDI (Spearman's ρ=0.283, P=0.021), BPRS (Spear-
man's ρ=0.410; P=0.001), and HAM-A (Spearman's ρ=0.330,
P=0.007). Interestingly, Attentional Impulsivity scores were strongly
associated with BDI (Spearman ρ=0.424, Pb0.001), HAM-A (Spear-
man's ρ=0.548, Pb0.001), and BPRS (Spearman ρ=0.363, P=0.003)
scores. Non-planning Impulsivity was not signiﬁcantly associated withTable 3
Psychiatric evaluation according to the presence of suicide risk (N=66).







9 (47.4%) 4 (8.5%) 0.001a
Bipolar disorder 4 (21.1%) 3 (6.4%) 0.099a
Type I bipolar 2 (10.5%) 1 (2.1%) n.s.a
Type II bipolar 2 (10.5%) 2 (4.3%) n.s.a
Current bipolar depression 3 (15.8%) 1 (2.1%) 0.069 a
Anxiety disorder 11 (57.9%) 18 (38.3%) n.s.a
Psychotic disorder 1 (5.3%) 2 (4.3%) n.s.a
Somatoform disorder 7 (36.8%) 3 (6.4%) 0.004a
Substance-related disorder 1 (5.3%) 1 (2.1%) n.s.a
Beck Depression Inventory 20.1 (11.0) 9.3 (9.1) b0.001b
Hamilton Anxiety Scale 14.8 (9.2) 8.6 (7.1) 0.006b
BPRS 12.9 (8.5) 8.7 (8.9) 0.020b
Barratt Impulsiveness Scale
Total 66.3 (12.7) 60.3 (10.2) 0.042b
Motor Impulsivity 24.1 (5.2) 19.9 (5.0) 0.005b
Attentional Impulsivity 19.8 (4.3) 18.5 (4.5) n.s.b
Nonplanning Impulsivity 22.4 (6.7) 21.8 (4.6) n.s.b
a Fisher's exact test.
b Mann–Whitney U test.BDI, HAM-A, or BPRS scores (PN0.1, for all). Table 4 stresses the greater
relevance of major depression to suicide risk. Motor impulsivity was
also a signiﬁcant predictor of suicide risk, but not frequency of seizures.
Residual analysis showed good ﬁt of themodel with the Hosmer Leme-
show test (P=0.744).
A split on motor impulsivity at the median on 21 points
(range=12–35 points) was used to categorize patients into two
groups, one with high and the other with low impulsivity. Next, par-
ticipants were grouped according to the presence of depression and
the level of motor impulsivity, and compared with respect to suicide
risk, as indicated in Table 5. The non-depressed/low motor impulsiv-
ity group signiﬁcantly differed with respect to suicide risk when com-
pared with the depressed/low motor impulsivity group (P=0.038)
and, principally, the depressed/high motor impulsivity group
(Pb0.001). It is interesting to note that with respect to suicide risk,
the non-depressed/low motor impulsivity group did not signiﬁcantly
differ from the non-depressed/high motor impulsivity group
(P=0.247), but the depressed/high motor impulsivity group did sta-
tistically differ from the non-depressed/high motor impulsivity group
(P=0.002). No other signiﬁcant differences were observed between
groups.
4. Discussion
The present data reinforce the idea that neuropsychiatric evalua-
tion in epilepsy must consider suicidality, because in TLE, suicide
risk is associated with psychiatric disorders, principally depression.
In line with this ﬁnding is a population case–control study in Den-
mark that showed a high risk of suicide among patients with epilepsy
and comorbid mood disorder (RR=19.9, 95% CI=12.7–31.2,
Pb0.0001) [25]. This Danish study analyzed 21,169 cases of suicide
and found the highest suicide risk in those with epilepsy and psychi-
atric comorbidities [25]. A recent Brazilian community-based study
also demonstrated the importance of psychiatric disorders in suicidal
thoughts, mainly anxiety (3-fold), depression (5-fold), and at least
two psychiatric diagnoses (22-fold) [11].
Depression is the commonest interictal psychiatric disorder in TLE
[26,27]. The importance of treating mental disorders, particularly de-
pression, in epilepsy is emphasized by its association with suicide
risk. We observed in this study that major depression was the main
variable related to suicide risk and the only psychiatric disorder sig-
niﬁcantly associated with suicide attempts. Indeed, several recent
studies address the relevance of identifying depression in epilepsy
[11,12,16,25,26], and the Neurological Disorders Depression Invento-
ry for Epilepsy (NDDI-E) [28,29] stands as a practical screening in-
strument (takes only about 3 minutes). The NDDI-E was speciﬁcally
developed to assess depression in epilepsy and also includes one
item related to suicidal thoughts (“I'd be better off dead”).
Abnormal serotonergic neurotransmission is demonstrated in de-
pression as well as in TLE and suicide [30,31]. It is suggested that com-
mon underlying pathways may link depression, suicide, and epilepsy
[1,32-34]. A low serotonergic state is linked to aggressive–impulsive
behaviors [7], and impulse control disorders are usually treated with
serotonergic drugs [35]. A FDG-PET study showed clinical improve-
ment and increased PFC metabolism in aggressive–impulsive patients
treatedwith a selective serotonin reuptake inhibitor [36]. Studies con-
ducted in rodents revealed that serotonergic dysfunction in PFC can
affect inhibitory response control [35]. Furthermore, perseverative
Table 5










Suicide risk present (n=19) 2 (8%) 5 (20.8%) 3 (50%) 9 (81.8%)
No suicide risk (n=47) 23 (92%) 19 (79.2%) 3 (50%) 2 (18.2%)
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propriate reactions to punishment or loss of reward, are associated
with low serotonin in PFC [37]. Thus, serotonergic dysfunction and
frontal lobe dysfunction are possible neurobiological underpinnings
related to depression and impulsivity leading to suicidal behavior in
TLE.
Frontal lobe dysfunction can be seen in TLE, and a role for PFC in
impulsivity, depression, and suicide has been proposed. Bilateral re-
duction in prefrontal metabolism is described in children with TLE
with aggressive behavior [38] and depressed patients with complex
partial seizures [39]. Raust et al. compared 30 euthymic suicidal pa-
tients with 39 control subjects and found that BIS Motor Impulsivity
scores, but not BIS Total or other BIS subscale scores, were signiﬁcant-
ly higher in the former group [8]. These authors point to dysexecutive
problems in patients with suicidal behavior who showed impairment
on cognitive domains such as visuospatial conceptualization, inhibi-
tory control, and visual attention (or reading ﬂuency), even after ad-
justment for motor impulsivity as a covariate [8]. A high prevalence
(29%) of impulse control disorders was reported in a sample of se-
verely depressed patients who exhibited higher Motor Impulsivity
scores than those without impulse control disorders, according to
the BIS [9]. A higher risk of suicide in patients with TLE with persev-
erative responses on the Wisconsin Card Sorting Test was also de-
scribed, suggesting the role of executive dysfunction in suicide risk
[12]. Impairment on conceptual ﬂexibility and problem solving, in a
context of negative thoughts, may lead to a poor ability to select the
appropriate social adaptation in different adversities faced by people
with epilepsy [12], leading to frustration and suicidal ideation.
On the basis of our results, depression showed an association with
impulsivity, mainly attentional but also motor impulsivity. In fact, an
association between attentional impulsivity and depression and
mania was previously described in bipolar patients, showing that im-
pulsivity could be an element of mood disorders itself [40]. Addition-
ally, motor impulsivity correlates with mania in bipolar disorder [40].
Hence it is plausible that negative affect associated with a cognitive
vulnerability, characterized by impairment in motor inhibitory con-
trol and the tendency to act on the spur of the moment, may lead to
suicidal behaviors in patients with TLE.
Attention-deﬁcit/hyperactivity disorder (ADHD) is an important
disorder related to pathological impulsivity [35]. However, ADHD di-
agnosis requires information about childhood behavior, and a signiﬁ-
cant portion of the sample had memory deﬁcits, especially common
in TLE, or was without a caregiver who could provide reliable infor-
mation, limiting the diagnosis of this disorder. To avoid selection
biases, ADHD diagnosis was not described and this is one of the limi-
tations of the present study. By the same token, considering that it
was difﬁcult to obtain complete information about the past history
of some patients, including child behavior, some diagnosis such as de-
pression, bipolar disorder, or impulsivity during childhood could have
been omitted, underestimating the lifetime diagnoses described in
this study.
There are other particular suicide risk factors in epilepsy such as
epilepsy type, localization, lateralization, and age at onset, as well as
stigma, psychosocial impact, peri-ictal behavior, and adverse effects
of AEDs on mood [12]. In our study, patients with suicide risk had a
higher frequency of seizures in the univariate analysis, but this didnot survive the logistic regression. This can be interpreted as a possi-
ble indirect association of seizure frequency with depressive disor-
ders, as refractory epilepsy is related to a high frequency of
depression [41]. It seems likely that adequate control of seizures can
contribute to the prevention of depression and, consequently, reduc-
tion in suicide risk [42]. In fact, clinical variables associated with epi-
lepsy, such as high seizure frequency, early onset, AED polytherapy,
and also a major depression history, are described as the typical ﬁnd-
ings in people with epilepsy who commit suicide. Suicide risk and vi-
olent suicidal methods are probably related to a history of depression
[3,12]. The importance of dysphoric mood was described in 5 suicides
registered among more than 10,000 patients of a North American
specialized epilepsy center [43]. Interestingly, all 5 patients had un-
dergone surgical treatment for epilepsy (3 had right temporal lobec-
tomy), and the authors suggested that suicidality may be related to
seizure control after longstanding epilepsy [43]. Kanner et al. de-
scribed postictal suicidal thoughts in 13% (no suicide attempt) of
100 consecutive patients with refractory partial epilepsy. Not surpris-
ingly, 77% of these patients with suicide ideation had a history of de-
pressive episodes [44].
It is worth noting that a history of suicide attempts is the most im-
portant predictor of suicide, as more than one-third of people with a
positive history attempt suicide again [1]. A Scandinavian population-
based study found that 46.2% of people with epilepsy who committed
suicide had previously attempted suicide [45], which suggests that at-
tention must be paid to subjects with a history of suicide attempts, as
in 23.3% of the present study sample, especially those with high sui-
cide risk (6.1%).
Lately, the role of AEDs in suicide has been debated. Based on a
meta-analysis conducted in 2008, the Food and Drug Administration
issued a warning about the risk of suicide and the use of 11 AEDs,
though only topiramate and lamotrigine reached statistical signiﬁ-
cance. This warning has been subject to criticism as most of the stud-
ies involved patients in polytherapy, ignoring the relevance of drug
interactions among AEDs [1]. Data described here showed no associ-
ation between the number of AEDs or the use of any speciﬁc AED
and suicide risk. Further, off-label studies showed that AEDs such as
carbamazepine, valproate, and phenytoin can be effective in reducing
impulsivity, mainly associated with aggressive behavior [7,46,47],
and thus could be useful in clinical practice to minimize impulsive be-
haviors related to suicide. However, though some AEDs can have a
positive impact on mood (e.g., lamotrigine), others are associated
with depression (e.g., ethosuximide, topiramate, vigabatrin, and ruﬁ-
namide) [46], and this should be taken into account in the neuropsy-
chiatric evaluation of suicide risk in epilepsy.
Ourﬁndings are limited by the sample size and selection bias toward
refractory TLE and must be seen in a context of a hospital setting which
includes people with more severe epilepsy and possibly higher suicide
risk. The absence of a control group and lack of information about the
neuropsychological proﬁle are other limitations of the present study.
Our data support the concept of a strong association between suicide
and depression in TLE. Common neurophysiological mechanisms may
lead to a low serotonin input into the PFC in depression, epilepsy and
deﬁcits in cognitive inhibition, all increasing the risk of suicidal and im-
pulsive behavior. Suicidal risk in epilepsy is determined by a complex
combination of different factors such as psychopathology (especially
749G.N.M. de Oliveira et al. / Epilepsy & Behavior 22 (2011) 745–749mood background), cognitive ﬂexibility, inhibitory control, personality
traits, problem-solving abilities, psychosocial stressors, and severity of
seizures, among others. Therefore, patients must be assessed individu-
ally, weighing howmuch each variable accounts for suicide risk. Suicide
prevention in this group is the most important reason for reducing sui-
cidality, especially looking after the most vulnerable group, patients
with past suicide attempts. Simultaneously, early diagnosis and treat-
ment of depression constitute an obvious strategy.
5. Conclusion
Whereas history of suicide attempt is the strongest risk factor for
suicide, depression is the most important psychiatric condition asso-
ciated with suicide risk in TLE. Motor impulsivity seems to be a rele-
vant component of suicidality in TLE. Notwithstanding, our data
suggest that impulsivity may be secondarily related to psychiatric
symptoms, more speciﬁcally depression. These data reinforce the rel-
evance of diagnosing and treating depression appropriately in epilep-
sy. We hypothesize that impairment in executive functioning may
underlie suicidality in patients with depression and motor impulsivi-
ty traits in TLE. Psychiatric evaluation must draw special attention
to mood, cognition (executive functioning), and impulsivity when
addressing suicide in TLE.
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